As shown in Supplementary Figure S11, Kaplan-Meier analyses revealed that, except LYPD6 and EPGN, the expression of ipr-DEGs were all significantly correlated with ccRCC patient survivals. The gene discussed is LYPD6; the disease is nonpapillary renal cell carcinoma.